Some works also attempted to establish prediction models for clinical biomarkers (such as ER and PR) as well as immunohistochemistry (IHC) subtypes of BC based on quantitative imaging features with a machine learning or deep learning approach (25–33). This evidence concerns the gene ESR1 and breast cancer.